Future Ventures

Decibel Bio is a plant biotechnology company that develops a crop epigenetic platform. This platform provides farmers with precise, in-season information about foliar sprays or seed treatments, enabling them to predict crop traits and agronomic outcomes more accurately than traditional methods. By using this platform, growers can enhance nutrient uptake and boost stress tolerance in plants, adapting to varying weather and market conditions.

Molten Salt Solutions, founded in 2018 and headquartered in Santa Fe, New Mexico, develops an advanced technology platform focused on the synthesis and purification of molten salt. The company specializes in producing large quantities of isotopically-enriched materials essential for advanced fission and fusion nuclear power applications. Its innovations provide critical chemistry and materials necessary for nuclear energy, addressing significant challenges in energy security and carbon emissions. By enabling rapid development and deployment of isotope enrichment technologies, Molten Salt Solutions positions itself as a key player in the evolving landscape of nuclear power.

Hephae Energy Technology is an energy company specializing in advanced drilling technology aimed at enhancing geothermal energy generation. The company provides an integrated drilling system designed to facilitate the safe, efficient, and scalable development of geothermal resources worldwide. By harnessing abundant geothermal heat, Hephae aims to reduce costs associated with drilling wells, making geothermal energy a more economically viable alternative within the energy sector. Their innovative approach enables the energy industry to access reliable technology for accurately and productively drilling geothermal wells, thereby contributing to the global shift toward sustainable energy solutions.

Vironexis Biotherapeutics is a biotechnology company focused on advancing immunotherapy for cancer treatment. The company specializes in AAV-delivered T-cell immunotherapy, utilizing a gene therapy platform that facilitates the development of off-the-shelf, single-dose gene therapies. This innovative approach aims to enhance patient outcomes by enabling healthcare professionals to leverage T-cell-mediated mechanisms for more effective cancer treatment. With its commitment to transforming the landscape of immunotherapy, Vironexis is positioned to make significant contributions to the future of cancer care.

Earthshot Labs is a developer of a climate mitigation platform focused on ecological restoration on a global scale. The company utilizes an AI-powered platform to connect investors, carbon buyers, and land stewards, facilitating the financing of projects that promote ecological restoration while ensuring equity for local communities. Its comprehensive tool allows users to algorithmically identify specific regenerative strategies tailored to individual land parcels, ultimately enabling clients to maximize both the natural and economic potential of their land. Through its innovative approach, Earthshot Labs aims to enhance ecosystem regeneration and contribute to climate solutions worldwide.

Xona Space Systems, Inc. is a company focused on developing and manufacturing position, navigation, and timing (PNT) satellite solutions. Established in 2019 and headquartered in San Mateo, California, the company is creating a constellation of low-cost, low-Earth orbit satellites designed to enhance navigation services for a variety of sectors, including smart transportation and infrastructure. Xona's flagship product, the Xona Pulsar, delivers high-power signals to support applications such as autonomous vehicles, unmanned aerial vehicles, and mobile robotics. The constellation aims to provide secure, resilient, and precise navigation and timing services essential for the safe and scalable operation of modern intelligent systems.

Traditional cameras rely on an imaging lens which typically consists of several lens elements and a light sensitive sensor. Cameras have been built like this since 1816. Glass has been historically used to make high quality optical elements. We are replacing these elements with deep neural networks that give extreme flexibility when designing our cameras. It allows us to squeeze a huge sensor into an ultra thin module that fits perfectly into a mobile device without the need for protruding bumps. Our cameras bring SLR image quality into your pocket.

Moonwalk Biosciences is a genomic medicine startup focused on developing precision epigenetic therapeutics. The company specializes in creating a profiling and engineering technology platform that leverages advanced artificial intelligence predictions to offer a comprehensive view of the epigenome in both health and disease states. This innovative approach aims to revolutionize therapy discovery and development, enabling healthcare providers to reprogram cells back to their healthy state.

Woola is a company that produces sustainable packaging materials from leftover sheep wool, aiming to replace traditional plastic bubble wrap. Its wool-based packaging is lightweight, protective, and compostable, allowing customers to reduce their plastic waste, particularly in online shopping. The company's approach emphasizes a closed-loop system, where its packaging can be reused, repurposed, or returned by users, ensuring that nothing goes to waste. By focusing on eco-friendly alternatives, Woola addresses the growing demand for sustainable packaging solutions in various industries.

Amplifier Therapeutics is a biopharmaceutical company dedicated to developing novel therapies targeting AMP-activated protein kinase (AMPK), a key regulator of cellular energy balance. The company's focus is on treating age-related disorders, including metabolic conditions, cardiovascular diseases, kidney diseases, and certain types of cancer, by activating AMPK to restore normal cellular function.

Lace Lithography is a technology company specializing in the development of advanced lithography solutions for semiconductor manufacturing. Their core innovation lies in a chip patterning technology that replaces traditional light-based methods with atomic-scale precision, enabling the production of smaller, more efficient chips. This breakthrough extends the limits of Moore's Law, allowing industries to continue advancing semiconductor technology in a cost-effective and energy-efficient manner.

Robust.AI, founded by Anthony Jules in 2019 and based in San Carlos, California, specializes in developing a robot cognitive platform that aims to solve complex robotics problems and make mobile robots widely usable across various industries. The company's technology combines AI, robotics, and human-centered design to create collaborative mobile robots that are safe, autonomous, and easy to integrate into existing workflows. Robust.AI has introduced two key products: Grace, a software suite, and Carter, a hardware concept. These innovations are particularly targeted at the warehousing industry, where automation is currently underutilized despite significant labor shortages impacting global supply chains.

OutcomeMD is a Los Angeles-based company that offers an advanced Software as a Service (SaaS) platform, OMD Platform. This platform enables healthcare providers across various specialties to consistently track and analyze patients' symptoms using validated Patient Reported Outcome Measures (PROMs). By doing so, OutcomeMD helps providers enhance patient care, celebrate their positive outcomes publicly, and foster word-of-mouth referrals. The platform also facilitates measurement-based care and outcome-driven decision support, contributing to precision medicine and improved healthcare practices.

Verdant Robotics, Inc., founded in 2018 and based in Hayward, California, specializes in artificial intelligence-driven robotic solutions for agriculture. The company develops advanced technologies that enable farmers to digitally map their fields and monitor each plant's health over time. Verdant's flagship product, the Model B Smart Sprayer, significantly reduces labor costs by over 50% and input costs by up to 96% while providing precise weeding and thinning for various crop types. Utilizing proprietary Bullseye targeting technology and a Pinpoint Spray System, Verdant promotes micro-fertilization and nutrient delivery, enhancing crop yields and efficiency. By leveraging robotics, computer vision, and machine learning, Verdant Robotics empowers growers of all sizes to optimize production and improve profitability in the agricultural sector.

Enriched Ag is a company focused on enhancing the resilience and profitability of agriculture through innovative technology. It has developed a data-driven insights platform designed to unlock the environmental and socio-economic value of grazing lands. This platform provides users with predictive analytics related to weather and forage, as well as tools for planning grazing and rotations. Additionally, it offers data and life cycle assessment estimates for greenhouse gas emissions associated with beef production, processing, and transportation. By delivering valuable insights, Enriched Ag aims to support farmers and ranchers in making informed decisions that contribute to sustainable agricultural practices.

Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.

YourChoice Therapeutics, Inc. is a biotechnology company based in Berkeley, California, founded in 2018. The company focuses on developing non-hormonal contraceptive products aimed at providing women with safe and effective birth control options. Its innovative technology is based on the concept of a "molecular condom," which utilizes an active compound to inhibit sperm motility, thereby preventing sperm from fertilizing the egg. This approach seeks to eliminate the risks and side effects commonly associated with traditional hormonal contraceptive methods, offering a promising alternative for those seeking safer birth control solutions.

Faeth Therapeutics is a healthcare company dedicated to enhancing cancer treatment through a deep understanding of the relationship between dietary nutrients and tumor growth. By aligning specific diets with tumor genotypes and treatment regimens, Faeth aims to limit the energy and resources that tumors need to proliferate, thereby improving patient outcomes in cancer therapy. Founded by leading researchers and clinicians, the company seeks to translate significant discoveries from cancer research laboratories into effective clinical practices, focusing on evidence-based approaches to optimize treatment strategies for cancer patients.

ALICE Technologies is a developer of an AI-powered construction simulation platform designed to optimize building processes. The platform utilizes advanced artificial intelligence to analyze complex project requirements, generating efficient schedules and resource allocations. This capability allows construction professionals to estimate costs and timelines accurately while adapting to changes throughout the construction cycle. By streamlining planning and execution, ALICE Technologies helps contractors and project owners reduce construction times and labor costs significantly, with typical savings of $30 million on projects valued at $500 million. The company collaborates with leading firms in the infrastructure and commercial construction sectors, enhancing their ability to manage projects effectively.

Osmind Inc. is a San Francisco-based public benefit corporation founded in 2020 that specializes in developing healthcare software tailored for mental health providers and their patients. The company focuses on advancing evidence-based medicine to support individuals suffering from moderate to severe mental health conditions. Osmind's electronic health record platform is designed specifically for clinicians and researchers, facilitating interventional treatment workflows. It includes features such as journaling tools and support for health plan reimbursement, empowering healthcare professionals to implement innovative therapeutic approaches and precision psychiatry. By providing robust technology, Osmind aims to inform best practices in patient care and contribute to the development of new life-saving mental health treatments.

64x Bio is a biotechnology company that specializes in accelerating the discovery of mammalian cell lines for biomanufacturing and therapeutic applications. The company has developed a high-throughput discovery and screening platform that integrates advanced computational design techniques. This platform enables the creation of highly optimized cell lines specifically tailored for the production of viral vectors, which are crucial for cell and gene therapies. By providing purpose-built genetically engineered cell lines, 64x Bio aims to enhance the efficiency of viral vector production, helping pharmaceutical and biotechnology companies improve their manufacturing capabilities while reducing associated costs.

Faeth Therapeutics is a healthcare company dedicated to enhancing cancer treatment through a deep understanding of the relationship between dietary nutrients and tumor growth. By aligning specific diets with tumor genotypes and treatment regimens, Faeth aims to limit the energy and resources that tumors need to proliferate, thereby improving patient outcomes in cancer therapy. Founded by leading researchers and clinicians, the company seeks to translate significant discoveries from cancer research laboratories into effective clinical practices, focusing on evidence-based approaches to optimize treatment strategies for cancer patients.

Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.

Ockam Inc. is a technology company founded in 2017 and headquartered in San Francisco, California, that specializes in providing a serverless platform for secure Internet-of-Things (IoT) development. The company offers tools that enable the seamless interconnection of hardware and software services, allowing for the secure exchange of information within connected systems. Its platform facilitates the management of identities, cryptographic keys, and credentials for various devices and applications. Ockam's solutions are designed to simplify the development process by eliminating the complexities associated with system administration, providing built-in security features such as end-to-end encryption and mutual authentication, and offering an open-source architecture that is secure-by-design. By connecting developers, engineers, and product managers, Ockam empowers organizations to build trust across their data exchanges in various networking environments.

Woola is a company that produces sustainable packaging materials from leftover sheep wool, aiming to replace traditional plastic bubble wrap. Its wool-based packaging is lightweight, protective, and compostable, allowing customers to reduce their plastic waste, particularly in online shopping. The company's approach emphasizes a closed-loop system, where its packaging can be reused, repurposed, or returned by users, ensuring that nothing goes to waste. By focusing on eco-friendly alternatives, Woola addresses the growing demand for sustainable packaging solutions in various industries.

New Culture Inc. is a food and beverage company based in San Francisco, California, specializing in the production of animal-free cheese. Founded in 2018, the company utilizes microflora to create dairy proteins and a variety of cheese products that are sustainable, healthy, and ethical. By focusing on innovative methods to produce cheese without animal ingredients, New Culture aims to reduce dependency on traditional dairy sources, offering consumers a delicious alternative that aligns with a more sustainable lifestyle.

Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health. As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.

MosaicML is a company focused on creating an efficient infrastructure for training large language models and improving the overall efficiency of neural networks. It develops software and artificial intelligence training algorithms that enhance the training process by utilizing algorithmic techniques such as sparsity and network pruning. These innovations allow users to effectively and securely train large-scale AI models on their proprietary data, while also optimizing for speed, quality, and cost. MosaicML aims to streamline the machine learning model recomposition process, making it easier for organizations to harness the power of AI in their operations.

Earthshot Labs is a developer of a climate mitigation platform focused on ecological restoration on a global scale. The company utilizes an AI-powered platform to connect investors, carbon buyers, and land stewards, facilitating the financing of projects that promote ecological restoration while ensuring equity for local communities. Its comprehensive tool allows users to algorithmically identify specific regenerative strategies tailored to individual land parcels, ultimately enabling clients to maximize both the natural and economic potential of their land. Through its innovative approach, Earthshot Labs aims to enhance ecosystem regeneration and contribute to climate solutions worldwide.

Hum Capital is the funding platform that connects great companies with the right capital. Hum offers companies raising up to $50 million the most efficient, transparent path to growth. Hum’s Intelligent Capital Market uses AI to translate volumes of a company’s financial data into the clearest picture of their value, so they can fundraise with confidence, on the best terms for their business. Investors on Hum’s platform gain investment insights and a personalized deal flow built on company data they can trust. For more information, visit HumCapital.com.

Latent AI, Inc. is a technology company based in Menlo Park, California, with an additional office in Skillman, New Jersey. Founded in 2018, it specializes in optimizing edge devices to facilitate smart Internet of Things (IoT) applications. The company's primary offering is the Latent AI Efficient Inference Platform (LEIP), which allows developers to train, quantize, and deploy edge AI neural networks. This platform supports adaptive artificial intelligence by providing a quantization optimizer that automates low-bit-precision training, enabling efficient neural network deployment for on-device intelligence and inference. Latent AI aims to accelerate AI implementation and streamline workflows for enterprises, making it easier for software developers to access and manage AI capabilities across various edge environments.

Osmind Inc. is a San Francisco-based public benefit corporation founded in 2020 that specializes in developing healthcare software tailored for mental health providers and their patients. The company focuses on advancing evidence-based medicine to support individuals suffering from moderate to severe mental health conditions. Osmind's electronic health record platform is designed specifically for clinicians and researchers, facilitating interventional treatment workflows. It includes features such as journaling tools and support for health plan reimbursement, empowering healthcare professionals to implement innovative therapeutic approaches and precision psychiatry. By providing robust technology, Osmind aims to inform best practices in patient care and contribute to the development of new life-saving mental health treatments.

Beeflow S.A., founded in 2016 and based in Buenos Aires, Argentina, specializes in professional pollination services that leverage scientific knowledge and technology to enhance bee health and efficiency. The company develops organic compounds that improve the immune systems of bees and train them to pollinate specific crops, such as blueberries, almonds, raspberries, and kiwifruit. By providing these specialized pollination services, Beeflow enables farmers to significantly increase crop yields, with reported improvements ranging from 20% to 90%, while simultaneously addressing the decline in bee populations. Through its innovative approach, Beeflow aims to support agricultural productivity and ecosystem sustainability.

MobileCoin, established in 2017 and headquartered in San Francisco, specializes in developing a cryptocurrency focused on privacy and security for peer-to-peer transactions. Its blockchain-based product aims to facilitate seamless mobile payments by enabling integration with popular messaging platforms like WhatsApp or Signal.

Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health. As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.

Sensei Biotherapeutics, Inc. is a clinical-stage biotechnology company based in Gaithersburg, Maryland, with an additional office in Boston, Massachusetts. Founded in 1999, the company specializes in developing precision cancer therapeutics, particularly next-generation immunotherapies. Sensei's proprietary drug discovery platform, ImmunoPhage, focuses on understanding the tumor microenvironment to create novel biologics that target tumor-specific antigens and activate both the innate and adaptive immune systems. The company is working on a range of investigational product candidates, including SNS-101, SNS-102, SNS-103, and SNS-20, which aim to address unmet needs in cancer treatment by selectively disabling immunosuppressive signals or activating immunostimulatory signals within the tumor microenvironment. Through its innovative approach and collaboration with experts in biology, immunology, and oncology, Sensei Biotherapeutics seeks to transform cancer treatment and improve outcomes for patients.

ATAI Life Sciences AG is a biotechnology company based in Munich, Germany, with additional offices in Berlin and London. Founded in 2018, the company focuses on developing innovative therapies for mental health disorders, including depression, anxiety, and substance use disorders. ATAI utilizes psychedelic compounds and other therapeutic methods to address these conditions, collaborating with various partners and research institutions to enhance its drug development pipeline. Its clinical-stage product portfolio features therapies such as COMP360 (Psilocybin therapy), PCN-101 (R-ketamine), and others derived from compounds like MDMA and ibogaine. By working with experts in the field, ATAI aims to ensure the efficacy and safety of its treatments. The company has garnered recognition for its contributions to mental health research and has secured partnerships and funding to further its initiatives in transforming mental health care.

ALICE Technologies is a developer of an AI-powered construction simulation platform designed to optimize building processes. The platform utilizes advanced artificial intelligence to analyze complex project requirements, generating efficient schedules and resource allocations. This capability allows construction professionals to estimate costs and timelines accurately while adapting to changes throughout the construction cycle. By streamlining planning and execution, ALICE Technologies helps contractors and project owners reduce construction times and labor costs significantly, with typical savings of $30 million on projects valued at $500 million. The company collaborates with leading firms in the infrastructure and commercial construction sectors, enhancing their ability to manage projects effectively.

Sensei Biotherapeutics, Inc. is a clinical-stage biotechnology company based in Gaithersburg, Maryland, with an additional office in Boston, Massachusetts. Founded in 1999, the company specializes in developing precision cancer therapeutics, particularly next-generation immunotherapies. Sensei's proprietary drug discovery platform, ImmunoPhage, focuses on understanding the tumor microenvironment to create novel biologics that target tumor-specific antigens and activate both the innate and adaptive immune systems. The company is working on a range of investigational product candidates, including SNS-101, SNS-102, SNS-103, and SNS-20, which aim to address unmet needs in cancer treatment by selectively disabling immunosuppressive signals or activating immunostimulatory signals within the tumor microenvironment. Through its innovative approach and collaboration with experts in biology, immunology, and oncology, Sensei Biotherapeutics seeks to transform cancer treatment and improve outcomes for patients.

TaiMei Technology is a digital innovator in the life sciences sector, specializing in research and development solutions. The company has created a comprehensive integrated digital platform that supports clinical research and offers deep insights into various aspects of drug development, including pharmacovigilance, marketing, and market access. By leveraging advanced technologies such as artificial intelligence, big data, cloud computing, and mobile internet, TaiMei Technology provides innovative solutions that enhance the efficiency of clinical research and improve the overall product lifecycle. Its platform is designed to facilitate the acceleration of product launches, elevate drug safety, increase drug accessibility, and alleviate the medical burden on both patients and healthcare providers.

Hum Capital is the funding platform that connects great companies with the right capital. Hum offers companies raising up to $50 million the most efficient, transparent path to growth. Hum’s Intelligent Capital Market uses AI to translate volumes of a company’s financial data into the clearest picture of their value, so they can fundraise with confidence, on the best terms for their business. Investors on Hum’s platform gain investment insights and a personalized deal flow built on company data they can trust. For more information, visit HumCapital.com.

Commonwealth Fusion Systems LLC is an energy research company based in Cambridge, Massachusetts, focused on developing fusion energy technology to address climate change. Established in 2017 as a spin-out from the Massachusetts Institute of Technology, the company utilizes rare-earth barium copper oxide superconductor technology to enhance fusion energy production. By integrating proven physics with advanced superconducting magnet technology, Commonwealth Fusion Systems aims to accelerate the commercialization of fusion energy. The company's efforts are directed toward designing and constructing fusion machines that promise limitless and clean energy, positioning them as a key player in the transition to renewable energy sources. Through collaboration with MIT's Plasma Science and Fusion Center, the company leverages decades of government-funded research to innovate within the private sector, ultimately contributing to the global pursuit of sustainable energy solutions.

Deep Genomics Inc. is an artificial intelligence therapeutics company based in Toronto, Canada, founded in 2014. The company focuses on developing individualized genetic medicines by utilizing AI systems to enhance various aspects of drug discovery and development, such as target discovery, lead optimization, toxicity assessment, and innovative trial design. Deep Genomics specializes in creating oligonucleotide therapies that address the genetic underpinnings of diseases at the RNA and DNA levels, targeting rare metabolic, ophthalmologic, and neurodegenerative disorders. Its AI-powered platform decodes the complexities of RNA biology, enabling the identification of novel therapeutic targets and mechanisms that traditional methods cannot access. This innovative approach positions Deep Genomics at the forefront of revolutionizing drug discovery, ultimately aiming to provide new treatments for currently untreatable diseases.

Enriched Ag is a company focused on enhancing the resilience and profitability of agriculture through innovative technology. It has developed a data-driven insights platform designed to unlock the environmental and socio-economic value of grazing lands. This platform provides users with predictive analytics related to weather and forage, as well as tools for planning grazing and rotations. Additionally, it offers data and life cycle assessment estimates for greenhouse gas emissions associated with beef production, processing, and transportation. By delivering valuable insights, Enriched Ag aims to support farmers and ranchers in making informed decisions that contribute to sustainable agricultural practices.

Hum Capital is the funding platform that connects great companies with the right capital. Hum offers companies raising up to $50 million the most efficient, transparent path to growth. Hum’s Intelligent Capital Market uses AI to translate volumes of a company’s financial data into the clearest picture of their value, so they can fundraise with confidence, on the best terms for their business. Investors on Hum’s platform gain investment insights and a personalized deal flow built on company data they can trust. For more information, visit HumCapital.com.

Ockam Inc. is a technology company founded in 2017 and headquartered in San Francisco, California, that specializes in providing a serverless platform for secure Internet-of-Things (IoT) development. The company offers tools that enable the seamless interconnection of hardware and software services, allowing for the secure exchange of information within connected systems. Its platform facilitates the management of identities, cryptographic keys, and credentials for various devices and applications. Ockam's solutions are designed to simplify the development process by eliminating the complexities associated with system administration, providing built-in security features such as end-to-end encryption and mutual authentication, and offering an open-source architecture that is secure-by-design. By connecting developers, engineers, and product managers, Ockam empowers organizations to build trust across their data exchanges in various networking environments.

The Boring Company is a construction firm specializing in tunneling infrastructure. It focuses on creating efficient, affordable, and safe underground networks for transportation, utilities, and freight, aiming to alleviate surface traffic congestion.

Commonwealth Fusion Systems LLC is an energy research company based in Cambridge, Massachusetts, focused on developing fusion energy technology to address climate change. Established in 2017 as a spin-out from the Massachusetts Institute of Technology, the company utilizes rare-earth barium copper oxide superconductor technology to enhance fusion energy production. By integrating proven physics with advanced superconducting magnet technology, Commonwealth Fusion Systems aims to accelerate the commercialization of fusion energy. The company's efforts are directed toward designing and constructing fusion machines that promise limitless and clean energy, positioning them as a key player in the transition to renewable energy sources. Through collaboration with MIT's Plasma Science and Fusion Center, the company leverages decades of government-funded research to innovate within the private sector, ultimately contributing to the global pursuit of sustainable energy solutions.

Latent AI, Inc. is a technology company based in Menlo Park, California, with an additional office in Skillman, New Jersey. Founded in 2018, it specializes in optimizing edge devices to facilitate smart Internet of Things (IoT) applications. The company's primary offering is the Latent AI Efficient Inference Platform (LEIP), which allows developers to train, quantize, and deploy edge AI neural networks. This platform supports adaptive artificial intelligence by providing a quantization optimizer that automates low-bit-precision training, enabling efficient neural network deployment for on-device intelligence and inference. Latent AI aims to accelerate AI implementation and streamline workflows for enterprises, making it easier for software developers to access and manage AI capabilities across various edge environments.

Mythic Inc. is a technology company specializing in the design and development of silicon chips and artificial intelligence processing units (IPUs). Founded in 2012 and headquartered in Redwood City, California, with an additional office in Austin, Texas, Mythic focuses on integrating AI capabilities into a wide range of devices, including fitness bands, hearing aids, self-driving cars, and robotic drones. The company leverages its unique analog compute-in-memory technology to create products like the M1076 Analog Matrix Processor and MP10304 Quad-AMP PCIe Card, delivering desktop-grade graphics processing in compact formats. With a diverse team of experts in neural networks, device physics, software design, and processor architecture, Mythic is committed to advancing AI solutions that perform reliably in real-world environments, enhancing the functionality of consumer electronics and other applications while maintaining performance and power efficiency.

Medcorder, Inc. is a technology company that has developed a mobile application aimed at enhancing communication and care coordination between patients, their families, and healthcare providers. Founded in 2019 and based in Redwood City, California, the Medcorder app allows users to record and transcribe conversations with their doctors, facilitating better understanding and retention of medical information. This functionality is particularly beneficial for patients with complex health conditions, as it supports the involvement of family members, even those who are geographically distant. By streamlining communication and reducing the need for repeated medical consultations, Medcorder aims to improve patient outcomes through better-informed decision-making and more efficient care management. The application is compatible with both Android and iOS devices, making it accessible to a wide audience.

Traditional cameras rely on an imaging lens which typically consists of several lens elements and a light sensitive sensor. Cameras have been built like this since 1816. Glass has been historically used to make high quality optical elements. We are replacing these elements with deep neural networks that give extreme flexibility when designing our cameras. It allows us to squeeze a huge sensor into an ultra thin module that fits perfectly into a mobile device without the need for protruding bumps. Our cameras bring SLR image quality into your pocket.